Health Catalyst Statistics
Share Statistics
Health Catalyst has 60.85M shares outstanding. The number of shares has increased by 6.16% in one year.
| Shares Outstanding | 60.85M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 2.43% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 58.43M |
| Failed to Deliver (FTD) Shares | 120 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 2.84M, so 4.67% of the outstanding shares have been sold short.
| Short Interest | 2.84M |
| Short % of Shares Out | 4.67% |
| Short % of Float | 4.88% |
| Short Ratio (days to cover) | 6.87 |
Valuation Ratios
The PE ratio is -4.42 and the forward PE ratio is 19.36.
| PE Ratio | -4.42 |
| Forward PE | 19.36 |
| PS Ratio | 1.77 |
| Forward PS | 1.4 |
| PB Ratio | 1.42 |
| P/FCF Ratio | -11.02 |
| PEG Ratio | n/a |
Enterprise Valuation
Health Catalyst Inc. has an Enterprise Value (EV) of 665.23M.
| EV / Earnings | -5.63 |
| EV / Sales | 2.25 |
| EV / EBITDA | -10.01 |
| EV / EBIT | -5.24 |
| EV / FCF | -14.04 |
Financial Position
The company has a current ratio of 4.42, with a Debt / Equity ratio of 0.63.
| Current Ratio | 4.42 |
| Quick Ratio | 4.42 |
| Debt / Equity | 0.63 |
| Total Debt / Capitalization | 38.67 |
| Cash Flow / Debt | -0.14 |
| Interest Coverage | -17.41 |
Financial Efficiency
Return on equity (ROE) is -0.32% and return on capital (ROIC) is -20.66%.
| Return on Equity (ROE) | -0.32% |
| Return on Assets (ROA) | -0.17% |
| Return on Capital (ROIC) | -20.66% |
| Revenue Per Employee | 227.64K |
| Profits Per Employee | -90.88K |
| Employee Count | 1.30K |
| Asset Turnover | 0.42 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 356.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -8.69% in the last 52 weeks. The beta is 1.32, so Health Catalyst 's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -8.69% |
| 50-Day Moving Average | 8.14 |
| 200-Day Moving Average | 7.3 |
| Relative Strength Index (RSI) | 46.65 |
| Average Volume (20 Days) | 512.18K |
Income Statement
In the last 12 months, Health Catalyst had revenue of $295.94M and earned -$118.15M in profits. Earnings per share was $-2.09.
| Revenue | 295.94M |
| Gross Profit | 131.83M |
| Operating Income | -126.90M |
| Net Income | -118.15M |
| EBITDA | -66.46M |
| EBIT | -126.90M |
| Earnings Per Share (EPS) | -2.09 |
Balance Sheet
The company has $106.28M in cash and $249.07M in debt, giving a net cash position of -$142.79M.
| Cash & Cash Equivalents | 106.28M |
| Total Debt | 249.07M |
| Net Cash | -142.79M |
| Retained Earnings | -1.12B |
| Total Assets | 813.05M |
| Working Capital | 133.63M |
Cash Flow
In the last 12 months, operating cash flow was -$33.08M and capital expenditures -$14.31M, giving a free cash flow of -$47.39M.
| Operating Cash Flow | -33.08M |
| Capital Expenditures | -14.31M |
| Free Cash Flow | -47.39M |
| FCF Per Share | -0.84 |
Margins
Gross margin is 44.55%, with operating and profit margins of -42.88% and -39.92%.
| Gross Margin | 44.55% |
| Operating Margin | -42.88% |
| Pretax Margin | -39.8% |
| Profit Margin | -39.92% |
| EBITDA Margin | -22.46% |
| EBIT Margin | -42.88% |
| FCF Margin | -16.01% |
Dividends & Yields
HCAT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -26.16% |
| FCF Yield | -9.75% |
Analyst Forecast
The average price target for HCAT is $11.5, which is 43.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $11.5 |
| Price Target Difference | 43.9% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Scores
| Altman Z-Score | -1.11 |
| Piotroski F-Score | 4 |